Researchers review the future of schizophrenia treatment, highlighting TAAR1 agonists, NMDA enhancers, and the gut-brain axis ...

It’s a frustration for both doctors who treat patients with schizophrenia and for people living with it: the most effective antipsychotic drugs have side effects, so unpleasant patients would rather ...

Milsaperidone is an active metabolite of iloperidone ...

A new study by researchers at King's College London has split schizophrenia risk into two genetically distinct pathways. One ...

Researchers used genomic structural equation modeling to separate schizophrenia-specific and shared bipolar genetic risks. Schizophrenia-unique variants were linked to lower IQ, while shared variants ...

Antibodies from llamas could be used to create a new generation of schizophrenia treatments that can effectively target the brain, rather than just reducing symptoms. This is the promise of a study ...

Researchers found that, compared with controls, intrinsic cellular age was slowed in schizophrenia cases in young adulthood, particularly in males, while phenotypic age was accelerated in later adults ...

Schizophrenia is a serious mental health disorder that is characterized by psychosis, making it difficult for a person to tell what is real. It impacts about 1% of the Canadian population and is ...

Three distinct symptoms characterized schizophrenia: positive, negative, and cognitive. Positive symptoms (delusions and hallucinations) improve with typical or atypical antipsychotic medications.

Health secretary probably referred to Harvard psychiatrist who says he’s ‘never used the word “cure” in my work’ ...